Highlights and Quick Summary
- EPS Growth (diluted) for the quarter ending September 30, 2022 was -71.43% (a -528.49% decrease compared to previous quarter)
- Year-over-year quarterly EPS Growth (diluted) increased by 233.32%
- Annual EPS Growth (diluted) for 2020 was 46.15% (a -1.43% decrease from previous year)
- Annual EPS Growth (diluted) for 2019 was 46.82% (a -8.96% decrease from previous year)
- Annual EPS Growth (diluted) for 2018 was 51.43% (a -30.17% decrease from previous year)
Visit stockrow.com/BBLG
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS Growth (diluted) of Bone Biologics Corp.
Most recent EPS Growth (diluted)of BBLG including historical data for past 10 years.Interactive Chart of EPS Growth (diluted) of Bone Biologics Corp.
Bone Biologics Corp. EPS Growth (diluted) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | -71.43% | 16.67% | -75.0% | – |
| 2021 | – | – | -21.43% | 46.15% | – |
| 2020 | – | – | 17.65% | 23.53% | 46.15% |
| 2019 | – | – | – | – | 46.82% |
| 2018 | – | – | – | – | 51.43% |
| 2017 | – | – | – | – | 73.65% |
| 2016 | – | – | – | – | -279.47% |
Business Profile of Bone Biologics Corp.
Sector: Healthcare
Industry: Medical Devices